ADVERTISEMENT

All You Need To Know Going Into Trade On July 27

Who’s buying and who’s selling, stocks in the news, key earnings update, brokerage radar and much more!

Commuters walk across London Bridge against a backdrop of Tower Bridge during sunrise in London, U.K. (Photographer: Chris Ratcliffe/Bloomberg)
Commuters walk across London Bridge against a backdrop of Tower Bridge during sunrise in London, U.K. (Photographer: Chris Ratcliffe/Bloomberg)

Asian stocks edged higher on Friday and headed for the strongest week since early June following a series of steps by China shifting to stimulus mode.

Japanese equities climbed for a fourth day, despite a drop of more than 5 percent in Nomura Holdings Inc. following a profit slide. Intensifying speculation about tweaks to the Bank of Japan’s stimulus programme saw 10-year yields triple this week, and they traded at 0.1 percent for a second day.

The Singapore-traded SGX Nifty, an early indicator of NSE Nifty 50 Index’s performance in India, traded 0.2 percent higher at 11,245 as of 7:23 a.m.

Short on time? Well, then listen to this podcast for a quick summary of the article!

BQ Live

Here’s a quick look at all that could influence equities today.

U.S. Market Check

  • U.S. equity indexes closed mostly lower Thursday thanks to Facebook Inc.’s historic plunge, as gains in the energy and industrial sectors weren’t enough to offset the social network’s meltdown.
  • The yield on 10-year Treasuries advanced one basis point to 2.98 percent.
Opinion
The End of Facebook's Easy Growth

Europe Market Check

  • European markets climbed after President Donald Trump agreed with European Commission chief Jean-Claude Juncker to suspend new tariffs while continuing to negotiate over trade.
All You Need To Know Going Into Trade On July 27
  • The euro declined 0.7 percent to $1.1643, the biggest drop in four weeks.
  • The British pound decreased 0.6 percent to $1.3108.
  • Germany’s 10-year yield gained one basis point to 0.40 percent.
  • Britain’s 10-year yield advanced less than one basis point to 1.278 percent.
Opinion
What Does the Apparent Trump-EU Trade Truce Mean for China?

Asian Cues

  • Japan’s Topix index advanced 0.2 percent as of 9:22 a.m. in Tokyo.
  • Australia’s S&P/ASX 200 Index gained 0.8 percent.
  • South Korea’s Kospi index was little changed.
  • Futures on Hong Kong’s Hang Seng fell 0.2 percent.
  • Futures on the S&P 500 Index were flat. The underlying gauge dropped 0.3 percent Thursday.
Opinion
Why Is China’s Currency Falling?

Here are some key events to watch out for this week:

  • Earnings season continues with Twitter on Friday.
  • U.S. gross domestic product probably increased by about 4.2 percent at an annualized rate in the second quarter, the most since 2014, economists forecast ahead of Friday’s data.

Commodity Cues

  • West Texas Intermediate crude advanced 0.4 percent to $69.60 a barrel.
  • Gold dipped 0.7 percent to $1,223.06 an ounce.

RBI Watch

  • RBI to auction Rs 12,000 crore of dated government bonds.
  • RBI to conduct Rs 22,500 crore of 14-day term repo-auction
  • RBI to release weekly forex, bank credit data.

Stocks To Watch

  • Hindalco’s Novelis to buy Aleris in $2.6 billion deal with assumption of debt.
  • Adani Ports signs a long-term regasification pact with GAIL for Dhamra LNG terminal.
  • IFB Industries to acquire industrial laundry equipment biz of Ramsons Garment for Rs 35 crore.
  • HPCL unlikely to buy Iran oil until India gets waiver from U.S. (Bloomberg)
  • Petronet LNG CEO expects BPCL Kochi plant to boost gas purchase. (Bloomberg)
Opinion
HDFC Bank Set To Launch Up To $2 Billion QIP Soon

Indian ADRs

All You Need To Know Going Into Trade On July 27

Offerings

  • HDFC Asset Management IPO gets demand for 5.52 times shares offered on second day sale; offer closes today.
Opinion
HDFC AMC’s Initial Public Offering: Here’s All You Need To Know

Nifty Earnings To Watch

  • HCL Technologies,
  • ICICI Bank
  • Reliance Industries

Other Earnings To Watch

  • Alembic Pharmaceuticals
  • Bank of Baroda
  • Coromandel International
  • Equitas Holdings
  • Heritage Foods
  • IL&FS Transportation
  • Indian Overseas Bank
  • Johnson Controls-Hitachi
  • JSW Energy
  • Jubilant Life
  • Mahindra & Mahindra Financial Services
  • Phillips Carbon
  • Prestige Estates Projects
  • Prism Johnson
  • Shoppers Stop
  • Welspun India

Earnings Reaction To Watch

Petronet LNG (Q1, QoQ)

  • Revenue up 6.2 percent to Rs 9,169 crore.
  • Net profit up 12.2 percent to Rs 587 crore.
  • Ebitda up 13.6 percent to Rs 934 crore.
  • Margin at 10.2 percent versus 9.5 percent.

Essel Propack (Q1, YoY)

  • Revenue up 13.3 percent at Rs 635.4 crore versus Rs 560.8 crore.
  • Net profit up 20.4 percent at Rs 41.3 crore versus Rs 34.3 crore.
  • Ebitda up 9.5 percent at Rs 111.6 crore versus Rs 101.9 crore.
  • Margin at 17.6 percent versus 18.2 percent.

Tata Metaliks (Q1, YoY)

  • Revenue up 21.8 percent at Rs 467.5 crore.
  • Net profit down 1 percent at Rs 30.6 crore.
  • Ebitda up 32.8 percent at Rs 66 crore.
  • Margin at 14.1 percent versus 12.9 percent.

Quess Corp (Q1, YoY)

  • Revenue up 51.7 percent at Rs 1,968.4 crore.
  • Net profit up 19 percent at Rs 54.4 crore.
  • Ebitda up 36.1 percent at Rs 102.5 crore.
  • Margin at 5.2 percent versus 5.8 percent.

WABCO India (Q1, YoY)

  • Revenue up 42.2 percent at Rs 747.3 crore.
  • Net profit up 38 percent at Rs 74.8 crore.
  • Ebitda up 26.2 percent at Rs 99.7 crore.
  • Margin at 13.3 percent versus 15 percent.

ITC (Q1, YoY)

  • Revenue up 8 percent at Rs 10,707 crore.
  • Net profit up 10 percent at Rs 2,819 crore.
  • Ebitda up 12 percent at Rs 4,202.5 crore.
  • Margin at 39.3 percent versus 37.6 percent.

Container Corporation of India (Q1, YoY)

  • Revenue up 7 percent at Rs 1,568 crore.
  • Net profit up 2 percent at Rs 252 crore.
  • Ebitda up 16 percent at Rs 390 crore.
  • Margin at 24.9 percent versus 23 percent.

Jubilant Industries (Q1, YoY)

  • Revenue up 17 percent at Rs 133 crore.
  • Net loss of Rs 1 crore versus net loss of Rs 2 crore.
  • Ebitda unchanged at Rs 7 crore.
  • Margin at 5.3 percent versus 6.1 percent.

Biocon (Q1, YoY)

  • Revenue up 21.2 percent at Rs 1,123.8 crore.
  • Net profit up 47.2 percent at Rs 119.7 crore.
  • Ebitda up 23.8 percent at Rs 237.8 crore.
  • Margin at 21.2 percent versus 20.7 percent.

Bharti Airtel (Q1, QoQ)

  • Revenue up 2.3 percent at Rs 20,080 crore.
  • Net profit up 17 percent at Rs 97 crore.
  • Ebitda down 3 percent at Rs 6,726 crore.
  • Margin at 33.5 percent versus 35.3 percent.
  • ARPU at Rs 105 versus Rs 116.

Cholamandalam Investment (Q1, YoY)

  • Net interest income up 20 percent at Rs 795 crore.
  • Net profit up 36 percent at Rs 285 crore.
  • AUM up 30 percent at Rs 46,663 crore.

Lakshmi Vilas Bank (Q1, YoY)

  • Net interest income down 40 percent at Rs 130 crore.
  • Net loss of Rs 124 crore versus net Profit of Rs 66 crore.
  • Provision down 82 percent at Rs 161.5 crore (QoQ)
  • GNPA at 10.73 percent versus 9.98 percent.
  • NPA at 5.96 percent versus 5.66 percent.

Tata Coffee (Q1, YoY)

  • Revenue up 14.9 percent at Rs 422.2 crore.
  • Net profit down 37.4 percent at Rs 21.6 crore.
  • Ebitda down 16.81 percent at Rs 66.3 crore.
  • Margin at 15.7 percent versus 21.7 percent.

Tinplate Company of India (Q1, YoY)

  • Revenue at Rs 568.6 crore versus Rs 236.5 crore.
  • Net profit at Rs 9.5 crore versus Rs 14.1 crore.
  • Ebitda at Rs 25.5 crore versus Rs 32 crore.
  • Margin at 4.4 percent versus 13.5 percent.

Bulk Deals

  • GMR Infra: Albula Investment Fund sold 3.02crore shares or 0.5 percent equity at Rs 18.01 each.
  • Shriram Transport Finance Co.: Association De Bienfaisance bought 12.14 lakh shares or 0.5 percent equity at Rs 1,379.36 each.
  • Just Dial: Acadian Emerging Markets Small Cap Equity Fund Llc bought 3.47 lakh shares or 0.5 percent equity at Rs 565.52 each.
  • Welspun Corp: Insight Solutions sold 2.15 crore shares or 8.1 percent equity at an average of Rs 112 each.

Safari Industries

  • White Oak India Equity Fund bought 1.54 lakh shares (0.7 percent) at Rs 700 each.
  • India Acorn Fund Ltd bought 1.31 lakh shares (0.6 percent) at Rs 700 each.
  • Tano India Private Equity Fund II sold 4.10 lakh shares (1.8 percent) at Rs 700.03 each.

Who’s Meeting Whom

  • Inox Leisure to meet Infina Finance on July 27.
  • Tata Metaliks to meet Centrum Broking on July 27.
  • Crompton Greaves Consumer Electrics to meet Amansa Holdings Pvt on July 27.

Insider Trades

  • Indo Rama Synthetics promoter Om Prakash Lohia acquired 80,180 shares on July 25.
  • Ruchi Soya promoters sold 7 lakh shares from July 24–25.
  • Vian Industries promoter Ripu Kundra acquired 10,000 shares on July 25.

Rupee

  • Rupee closed at 68.67/$ on Thursday from 68.79/$ on Wednesday

F&O Cues

  • Nifty August futures closed trading at 11,201.3 premium of 34 points versus 31points.
  • Across series: Nifty open interest up 2 percent; Bank Nifty open interest up 31 percent.
  • Rollover: Nifty at 74 percent, Bank Nifty at 78 percent.
  • India VIX ended at 12.02, down 1.5 percent.
  • Max open interest for Aug series at 11,500 Call (open interest at 23.9 lakh, up 20 percent)
  • Max open interest for Aug series at 11,000 Put (open interest at 32.4 lakh, up 29 percent)

Put Call Ratio

  • Nifty PCR at 1.72 versus 1.89
  • Nifty Bank  PCR at 1.36 versus 1.11

Brokerage Radar

Credit Suisse On Maruti Suzuki

  • Maintained ‘Neutral’; target price raised to Rs 10,300 from Rs 9,800.
  • Q1 revenue and Ebitda in line; net profit below estimates due to lower other income.
  • Maruti has chosen not to take any price hikes.
  • Gross margins contracted on adverse commodity prices.
  • Maruti continues to focus on increasing market share further.
  • Given premium valuations, expect stock to time-correct for now.

Credit Suisse On Yes Bank

  • Maintained ‘Neutral’ with target price of Rs 395.
  • Loan growth remains strong driven by retail segment.
  • Asset quality stable with net slippage at 0.6 percent.
  • Capital is needed to maintain current pace of growth.

Brokerages On Bharti Airtel

BoFAML

  • Maintained ‘Buy’ with target price of Rs 480.
  • Q1FY19: Inline Ebitda; Small profit due to tax credits.
  • Steady improvement in Africa continues.
  • Company continue to focus on cost-control and gain market share.

UBS

  • Maintained ‘Buy’ with target price of Rs 520.
  • Q1FY19: Respectable performance amidst a tough environment.
  • Africa momentum remains strong with revenue growth and margin improvement.
  • Bharti Airtel has managed to hold its market share better than peers.

Brokerages On ITC

JPMorgan

  • Maintained ‘Overweight’ with target price of Rs 335.
  • 1QFY19 earnings were ahead of our estimates; Good start to FY19.
  • Cigarette: Good performance; volume growth surprises positively.
  • Other FMCG: Impressive revenue growth and profitability gains.
  • Paper division: Good margin delivery.
  • Agri division: Adverse mix weighs on Ebit.
  • Hotel division: Good Q1.

UBS

  • Maintained ‘Buy’ with target price of Rs 350.
  • Overall performance creditable as it comes on a normalised base.
  • Delivered positive cigarette volume of 2 percent (YoY).
  • Positive volume growth is sustainable and could improve from here on.
  • Other FMCG business grew despite a high base.

Credit Suisse

  • Maintained ‘Outperform’; target price raised to Rs 360 from Rs 350.
  • Cigarette business seeing a revival, potential re-rating could start playing out.
  • Cigarette volumes likely to have grown 1-2 percent which is a significant improvement.
  • Q1 net profit ahead of estimates; Ebitda growth highest in nine quarters.

Brokerages On Colgate-Palmolive

Credit Suisse

  • Maintained ‘Neutral’; target price cut to Rs 1,150 from Rs 1,225.
  • Volume and market share trends weaken further.
  • Delivered very strong Ebitda margin driven by gross margins.
  • Since GST rate cuts, there has been steep jump in margins.
  • Colgate is still struggling in naturals.

JPMorgan

  • Maintained ‘Overweight’ with target price of Rs 1,400.
  • Q1 a mixed bag: Revenue growth remains unexciting, earnings beat led by margins.
  • Market share trends were soft.
  • Expect gradual volume growth revival in coming quarters.
  • Healthy FCF generation, return ratios and an improved dividend payout to support stock.

UBS on Petronet LNG

  • Maintained ‘Buy’ with target price of Rs 245.
  • Q1 net profit ahead of estimates driven by higher than expected re-gas margins.
  • Higher re-gas tariffs and operational efficiencies from higher volumes drove margins.
  • Positive sentiments should be driven by delay in commissioning of Mundra re-gas terminal.
  • Expect stock to react positively.

UBS on Quess Corp

  • Maintained ‘Buy’; target price cut to Rs 1,345 from Rs 1,360.
  • Revenue growth remained strong.
  • Margins impacted by mix of factors.
  • Positive on strategic investments.
  • Near term profitability to be adversely impacted due to investments.

JPMorgan on Shriram Transport

  • Maintained ‘Overweight’ with target price of Rs 1,700.
  • Net profit driven by loan growth and sharply reduced credit cost.
  • IND-AS accounting shift beneficial to both EPS & BPS.
  • Loan growth at 22 percent running above forecast.
  • Increase in axle load norms to improve earnings of core customers.

JPMorgan On Container Corporation

  • Maintained ‘Overweight’ with target price of Rs 875.
  • Operating performance continues to improve in Q1.
  • Margin improvement continues as rail freight expense remained flat.
  • Lead distance continues to weigh on top-line performance.
  • Expect 14 percent earnings CAGR over FY18-20 driven by margin improvement.

JPMorgan On Crompton Consumer

  • Maintained ‘Overweight’ with target price of Rs 300.
  • Q1 numbers ahead of estimates, good start to the year.
  • Good delivery by ECD segment; Lighting hits a blip on negligible government business.
  • Go-To-Market roll-out, fast LED replacement and scale-up of new categories to drive healthy revenue growth over the next 2-3 years.
  • Success of new product launches and market share gains key positives.

Brokerages On Dr. Reddy’s Labs

Citi

  • Maintained ‘Neutral’ with target price of Rs 2,270.
  • Strong headline number but likely to normalise.
  • Slight delay in expected launch timelines of gNuvaring & gCopaxone.
  • Near term prospects dependent on gSuboxone, gNuvaring, gCopaxone.

Credit Suisse

  • Maintained ‘Underperform’ with target price of Rs 1,865.
  • Suboxone, lower R&D, low tax lead to beat in results.
  • Nuvaring further delayed; more competition expected in key products in FY19.
  • Suboxone sales was $17-18 million while base business U.S. sales declined 2 percent (QoQ).

Goldman Sachs

  • Maintained ‘Neutral’ target price cut to Rs 2,200 from Rs 2,270.
  • Pushback the expected launch time of Suboxone by another quarter to 4QFY19.

UBS

  • Maintained ‘Neutral’ with target price of Rs 2,480.
  • Delays to key launches likely to drive consensus downgrades.
  • First quarter aided by gSuboxone and a lower tax expense.
  • See reduced opportunities for niche products in pipeline.
  • Base business continued to saw pricing erosion led by gDacogen and gToprol XL.